- Home
- BHFAO vs INM Comparison
BHFAO vs INM Comparison
Compare BHFAO & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BHFAO | INM |
|---|---|---|
| Founded | N/A | 1981 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Life Insurance | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 7.1M |
| IPO Year | 2018 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BHFAO | INM |
|---|---|---|
| Price | $12.70 | $1.33 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 40.8K | ★ 51.9K |
| Earning Date | N/A | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 23.06 | ★ 62.68 |
| EPS | ★ 2.84 | N/A |
| Revenue | ★ $6,766,000,000.00 | $4,942,633.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $26.00 |
| P/E Ratio | $4.64 | ★ N/A |
| Revenue Growth | ★ 43.23 | 7.50 |
| 52 Week Low | $13.09 | $0.58 |
| 52 Week High | $18.18 | $2.33 |
Technical Indicators
Market Signals| Indicator | BHFAO | INM |
|---|---|---|
| Relative Strength Index (RSI) | 23.23 | 43.34 |
| Support Level | N/A | $1.25 |
| Resistance Level | $14.75 | $1.42 |
| Average True Range (ATR) | 0.24 | 0.05 |
| MACD | -0.12 | 0.00 |
| Stochastic Oscillator | 0.01 | 7.69 |
Price Performance
Historical ComparisonAbout BHFAO Brighthouse Financial Inc. Depositary Shares 6.75% Non-Cumulative Preferred Stock Series B
Brighthouse Financial Inc is a United States-based provider of annuity products and life insurance through independent distribution channels and marketing arrangements with distribution partners. Its segments are: Annuities, that derives majority of the revenue, includes variable, fixed, index-linked, and income annuities; The life segment includes variable, term, universal, and whole life policies; The Run-off segment consists of products that are no longer actively sold and are separately managed, including ULSG, structured settlements, pension risk transfer contracts, certain company-owned life insurance policies and certain funding agreements; and The Corporate & Other segment consists of activities related to funding agreements associated with the company.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.